WHITE PLAINS, N.Y., April 10 /PRNewswire/ -- The Leukemia & Lymphoma
Society has appointed John Walter as its president and chief executive
officer, with the task of leading the world's largest organization
dedicated to funding blood cancer research as it strives to find cures and
prolong and enhance the lives of patients with leukemia, lymphoma and
(Photo: http://www.newscom.com/cgi-bin/prnh/20080410/NYTH074 )
Walter, who has been with LLS since 1995, most recently as chief
operating officer, succeeds Dwayne Howell, Ph.D., who retired in February.
"After conducting a nationwide search, the LLS Board of Directors
agreed that John Walter was the best candidate to steer us as we move
toward achieving our mission of curing blood cancers and improving the
lives of patients and their families," said LLS Chairman David Frantze.
"The Leukemia & Lymphoma Society is a $300 million plus organization
committed to identifying the best scientists in the world in the field of
blood cancer research and providing the funding to help them find cures and
better therapies. In John, we have somebody at the helm with the vision and
leadership qualities to provide support for our patients in their journey
dealing with these devastating diseases."
Walter started his career at LLS as senior vice president of finance
and information technology, during which time he enhanced the efficiencies
and internal controls of the organization by centralizing all finance and
treasury operations in the United States and Canada. He also established
LLS's information technology and Web functions.
He served as chief financial officer, and then, as executive vice
president, strategic alliances and new business development he designed and
implemented LLS's Co-Pay Assistance Program, a service that helps blood
cancer patients with their health insurance premiums and prescription drug
He came to LLS from the March of Dimes, where he worked for nine years.
He had previously worked at Donaldson, Lufkin & Jenrette and at
Bristol-Myers Squibb, where he had broad international experience.
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society(R), headquartered in White Plains, NY,
with 68 chapters in the United States and Canada, is the world's largest
voluntary health organization dedicated to funding blood cancer research
and providing education and patient services. The LLS mission: Cure
leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality
of life of patients and their families. Since its founding in 1949, LLS has
invested more than $550 million in research specifically targeting
leukemia, lymphoma and myeloma. Last year alone, LLS made 5.1 million
contacts with patients, caregivers and healthcare professionals.
For more information about blood cancer, visit www.LLS.org or call the
LLS Information Resource Center (IRC), a call center staffed by master's
level social workers, nurses and health educators who provide information,
support and resources to patients and their families and caregivers. IRC
information specialists are available at (800) 955-4572, Monday through
Friday, 9 a.m. to 6 p.m. ET.
Contact: Andrea Greif
SOURCE The Leukemia & Lymphoma Society